• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHS2000182 阿贝西利片 abemaciclib Tablet Chemical Drugs(2.4) Import Drug Application 2020-12-28 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc Certificate Issued 2022-01-06 view
JXHS2000184 阿贝西利片 abemaciclib Tablet Chemical Drugs(2.4) Import Drug Application 2020-12-28 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc Certificate Issued 2022-01-06 view
JXHS2000183 阿贝西利片 abemaciclib Tablet Chemical Drugs(2.4) Import Drug Application 2020-12-28 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc Certificate Issued 2022-01-06 view
CYSB2000247 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-10-30 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2021-08-06 view
JXHS2000161 注射用盐酸吉西他滨 gemcitabine hydrochloride Lyophilized Chemical Drugs(2.4) Import Drug Application 2020-11-09 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Vianex SA Certificate Issued 2021-07-26 view
JXHS2000160 注射用盐酸吉西他滨 gemcitabine hydrochloride Lyophilized Chemical Drugs(2.4) Import Drug Application 2020-11-09 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Vianex SA Certificate Issued 2021-07-26 view
JXHB2000015 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Supplementary Application 2020-08-25 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-05-09 view
JXHB2000014 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Supplementary Application 2020-08-25 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-05-09 view
JXSS2000064 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Import Drug Application 2020-12-23 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV In Review 2021-05-09 view
JXHL2100113 LOXO-305片 pirtobrutinib Tablet Chemical Drugs(1) Import Drug Application 2021-04-08 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-04-07 view
JXHL2100114 LOXO-305片 pirtobrutinib Tablet Chemical Drugs(1) Import Drug Application 2021-04-08 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-04-07 view
JXHL2100115 LOXO-305片 pirtobrutinib Tablet Chemical Drugs(1) Import Drug Application 2021-04-08 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-04-07 view
JXSL2100045 LY3471851注射液 Injection Biological Products(1) Import Drug Application 2021-03-31 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-30 view
JXHL2100092 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-03-19 view
JXHL2100091 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-03-19 view
JXSB2100025 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXHL2100090 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-03-19 view
JXSB2100024 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2100023 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXHL2100093 LOXO-305 pirtobrutinib Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc In Review 2021-03-19 view